ETF Series Solutions Trust Range Cancer Therapeutics ETFCNCR
CNCR
$14.18
1.98%
Market Cap: $16.7M
0
Funds holding %
of 6,686 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
3.02% less ownership
Funds ownership: 11.81% [Q1] → 8.79% (-3.02%) [Q2]
25% less funds holding
Funds holding: 16 [Q1] → 12 (-4) [Q2]
46% less capital invested
Capital invested by funds: $2.61M [Q1] → $1.4M (-$1.21M) [Q2]
75% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 4
80% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 5
Research analyst outlook
We haven’t received any recent analyst ratings for CNCR.